IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patientsYunfeng Ma, Jiru Xu, Yi Ren et al.|Advances in Clinical and Experimental Medicine|2017Cited by 248
Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancerYunfeng Ma, Jiru Xu, Chen Chen et al.|Oncotarget|2016Cited by 47
Interleukin (IL)-24 transforms the tumor microenvironment and induces anticancer immunity in a murine model of colon cancerYunfeng Ma, Yanhong Ji, Yi Ren et al.|Molecular Immunology|2016Cited by 33